Literature DB >> 8129620

Identification of three N-linked glycans in the V4-V5 region of HIV-1 gp 120, dispensable for CD4-binding and fusion activity of gp 120.

A Hemming1, A Bolmstedt, B Jansson, J E Hansen, B Travis, S L Hu, S Olofsson.   

Abstract

Site-directed mutagenesis was used to study the biological significance of three N-linked glycans (linked to Asn406, Asn448, and Asn463), situated in the CD4-binding region of gp120. Mutagenesis was carried out in a phage M13 system, and the mutated env genes were inserted into recombinant vaccinia virus (r-vaccinia virus). To evaluate if the level of expression affected the biological phenotype of mutant gp120, we expressed the envelope glycoproteins using either a weak (7.5 K) or a strong (11 K) promoter of vaccinia virus. The expression of mutated env proteins was analyzed after infecting CD4-expressing HeLa cells with the r-vaccinia virus, by monitoring the ability of the infected cells to generate CD4-dependent syncytia. Env gene products lacking all three glycans as well as env gene products lacking different permutations of one or two glycans were analyzed. All mutated gp120 species had the expected electrophoretical mobility as anticipated from elimination of one, two, and three N-linked glycans, respectively. Moreover, all mutant env gene products demonstrated the same capacity to induce formation of syncytia, irrespective of using the weak or strong promoter for expression. These data indicate that the three N-linked glycans studied are dispensable for HIV env gene products to function in CD4-binding and the subsequent fusion step.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129620     DOI: 10.1007/bf01310571

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.

Authors:  A Hemming; A Bolmstedt; P Flodby; L Lundberg; M Gidlund; H Wigzell; S Olofsson
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.

Authors:  B D Walker; M Kowalski; W C Goh; K Kozarsky; M Krieger; C Rosen; L Rohrschneider; W A Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis.

Authors:  K L Nakamaye; F Eckstein
Journal:  Nucleic Acids Res       Date:  1986-12-22       Impact factor: 16.971

5.  The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector.

Authors:  K Kuroda; H Geyer; R Geyer; W Doerfler; H D Klenk
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

6.  Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins.

Authors:  A Bolmstedt; A Hemming; P Flodby; P Berntsson; B Travis; J P Lin; J Ledbetter; T Tsu; H Wigzell; S L Hu
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

7.  Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins.

Authors:  S Vidal; G Mottet; D Kolakofsky; L Roux
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.

Authors:  R A Gruters; J J Neefjes; M Tersmette; R E de Goede; A Tulp; H G Huisman; F Miedema; H L Ploegh
Journal:  Nature       Date:  1987 Nov 5-11       Impact factor: 49.962

9.  Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.

Authors:  S Modrow; B H Hahn; G M Shaw; R C Gallo; F Wong-Staal; H Wolf
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

10.  Cross-neutralizing antibodies in rabbits immunized with HIV-1 gp160 purified from simian cells infected with a recombinant vaccinia virus.

Authors:  J Klaniecki; T Dykers; B Travis; R Schmitt; M Wain; A Watson; P Sridhar; J McClure; B Morein; J T Ulrich
Journal:  AIDS Res Hum Retroviruses       Date:  1991-10       Impact factor: 2.205

View more
  5 in total

1.  Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques.

Authors:  W M Blay; S Gnanakaran; B Foley; N A Doria-Rose; B T Korber; N L Haigwood
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 2.  Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

Authors:  F Benjelloun; P Lawrence; B Verrier; C Genin; S Paul
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

3.  Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.

Authors:  A Hemming; G J Gram; A Bolmstedt; B Losman; J E Hansen; A Ricksten; S Olofsson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.

Authors:  Eden P Go; Janet Irungu; Ying Zhang; Dilusha S Dalpathado; Hua-Xin Liao; Laura L Sutherland; S Munir Alam; Barton F Haynes; Heather Desaire
Journal:  J Proteome Res       Date:  2008-03-11       Impact factor: 4.466

5.  Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope.

Authors:  Art F Y Poon; Fraser I Lewis; Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  PLoS Comput Biol       Date:  2006-12-08       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.